COMPARATIVE STUDY Nasotracheal Fiberoptic Intubation: Patient Comfort, Intubating Conditions and Hemodynamic Stability During Conscious Sedation with Different Doses of Dexmedetomidine

Abstract The study aims to evaluate the efficacy of two doses of dexmedetomidine for sedation during awake fiberoptic intubation (AFOI). The study was designed in a prospective, randomized, double-blinded manner and car-ried out in an academic medical university. Forty young co-operative patients aged 15–45 years of either sex belonging to ASA class I-II, planned for elective maxillo-facial surgery formed the study group. All patients received midazolam 0.05 mg/kg, glycopyrrolate 0.2 mg, ondanse-tron 4 mg, and ranitidine 50 mg IV 15 min before as pre-medication, oxygen by nasal cannula, and topical local anesthetics to the airway. Patients were randomly assigned to one of the groups; dexmedetomedine 1 lg/kg IV (Group L), or dexmedetomidine 1.5 lg/kg IV (Group H). Obser-ver’s Assessment of Alertness/Sedation (OAA/S) was assessed. Primary outcome measurements were: HR, MAP, SpO2 and EtCO2 and secondary outcome measurements were: intubation scores by vocal cord movement, coughing and limb movement, fiberoptic intubation comfort score, nasotracheal intubation score and airway obstruction score. On the first post-operative day, recall, level of discomfort during fiberoptic intubation, adverse events and satisfaction score were also assessed. There were no significant hemodynamic differences between the two groups. OAA/S was significantly better with dexmedetomidine 1.5 lg/kg (p \ 0.05) and patients were significantly calmer, more cooperative and satisfied during awake fiberoptic intuba-tion with dexmedetomidine 1.5 lg/kg with fewer transient adverse effects. Dexmedetomidine 1.5 lg/kg proved to be more effective for sedation for awake fiberoptic intubation